CytomX Therapeutics
IPOHome - CytomX
Public · United States · $20.0M raised
- Headquarters
- California
- Business Model
- B2B
- Website
- cytomx.com
- Total Funding
- $20.0M
- Last Round
- $20.0M Series C
- Rounds
- 1
- Type
- Public
About
Biopharmaceutical company developing Probody therapeutics, antibody prodrugs activated in tumor microenvironments.
Summary
CytomX Therapeutics is a Biotech company based in United States. It has raised $20.0M in total across 1 round. Investors include Pfizer Ventures, Third Rock Ventures and Canaan Partners.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2026
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...